Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Antithrombin III

recombinant antithrombin III
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Antithrombin III, covering 2015-01-13 to 2015-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO [Phase 4]

See pricing